The Latest Breaking News from Purdue Pharma

When McKinsey Comes to Town review: the book to consult on opioids, China and more

Walt Bogdanich and Michael Forsythe of the New York Times have done their homework on the management giant

The Guardian - US · Oct 29, 2022

Ex-owner of Philly pharmacy that pushed more OxyContin than any other US drug store is sentenced to prison

PHILADELPHIA — The longtime owner of a Northeast Philadelphia pharmacy that once prescribed more OxyContin than any drug store in the country has been sentenced to prison and ordered to pay more than $4 million to settle claims of defrauding the government.

The Philadelphia Inquirer · Oct 4, 2022

How McKinsey cashed in by consulting for both companies and their regulators

When McKinsey Comes to Town authors Walt Bogdanich and Michael Forsythe say the consulting firm helped companies boost tobacco and opioid sales — while at the same time working for the FDA.

WEKU · Oct 3, 2022

J.D. Vance has a Purdue problem

The U.S. Senate candidate, who founded an anti-opioid non-profit, has several close ties to Purdue Pharma

Salon · Aug 20, 2022

New book chronicles how America's opioid industry operated like a drug cartel

Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel.

WEKU · Aug 2, 2022

The opioid crisis isn’t just the Sacklers’ fault – and making Purdue Pharma pay isn’t enough on its own to fix the pharmaceutical industry’s deeper problems

You may have heard of the Sackler family and the role that they and their privately held company, Purdue Pharma, played in the opioid crisis. One TV series depicting the family as a villainous clan has earned 14 Emmy nominations. Another is in the works.

The Conversation · Jul 26, 2022

$150M is not enough: Canada’s proposed Purdue Pharma settlement for opioid damages is paltry and won’t prevent future crises

On June 29, Canadian federal and provincial governments reached a proposed $150-million settlement with Purdue Pharma Canada, makers of OxyContin, an opioid-based pain medication. The settlement is intended to recover the health-care costs related to the damaging effects from the sale and marketing of OxyContin.

The Conversation · Jul 7, 2022

Lynn Schmidt: America's addiction nightmare comes home

A few weeks ago, my husband and I lost a friend to an opioid overdose. He was not the first person we knew who died from an overdose, but he was perhaps the closest. And while I am still working through the five stages of grief (denial, anger, bargaining, depression…

St. Louis Post-Dispatch · May 12, 2022

Ohio judge hears if pharmacy chains should pay for driving opioid crisis

CVS, Walgreens and Walmart Were found to recklessly dispense narcotic painkillers in two Ohio counties, fueling a drug epidemic

The Guardian - US · May 10, 2022

Purdue Pharma squares off with DOJ Over $6 billion OxyContin deal

A $6 billion deal hangs in the balance as OxyContin maker Purdue Pharma LP and its wealthy owners square off against the U.S. Justice Department over the firm’s opioid lawsuit settlement.

Tribune News Service · Apr 29, 2022